Abstract
Abstract
Prostate cancer is a highly heterogeneous disease and typically multiple distinct cancer foci are present at primary diagnosis. Molecular classification of prostate cancer can potentially aid the precision of diagnosis and treatment. A promising genomic classifier was published by The Cancer Genome Atlas (TCGA), successfully classifying 74% of primary prostate cancers into seven groups based on one cancer sample per patient. Here, we explore the clinical usefulness of this classification by testing the classifier’s performance in a multifocal context. We analyzed 106 cancer samples from 85 distinct cancer foci within 39 patients. By somatic mutation data from whole-exome sequencing and targeted qualitative and quantitative gene expression assays, 31% of the patients were uniquely classified into one of the seven TCGA classes. Further, different samples from the same focus had conflicting classification in 12% of the foci. In conclusion, the level of both intra- and interfocal heterogeneity is extensive and must be taken into consideration in the development of clinically useful molecular classification of primary prostate cancer.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87–108,
https://doi.org/10.3322/caac.21262
(2015).
2. D’Amico, A. V. Combined-modality staging for localized adenocarcinoma of the prostate. Oncology (Williston Park, N.Y.) 15, 1049–1059; discussion 1060–1042, 1064–1045, 1069–1070,1073–1045 (2001).
3. Grönberg, H. et al. Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study. The Lancet Oncology 16, 1667–1676,
https://doi.org/10.1016/S1470-2045(15)00361-7
(2015).
4. Barbieri, C. E., Demichelis, F. & Rubin, M. A. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity. Histopathology 60, 187–198,
https://doi.org/10.1111/j.1365-2559.2011.04041.x
(2012).
5. Kaffenberger, S. D. & Barbieri, C. E. Molecular subtyping of prostate cancer. Current Opinion in Urology 26, 213–218,
https://doi.org/10.1097/MOU.0000000000000285
(2016).
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献